A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors
Clinical trial NCT00920764 · COMPLETED
Trial details
- NCT number
- NCT00920764
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2010-04-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.